Delivery Order SPE2DB22D2206-SPE2DB25FJK02
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for the supply of Rifampin 300 mg capsules (60-count units) at a ceiling value of $1,720.96. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by July 29, 2025. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,200.66 by the Defense Logistics Agency for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-competitive contract awarded on August 26, 2025, with a completion date of August 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order from the Defense Logistics Agency (DLA) for Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,763.68. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, operates under firm fixed-price terms with no set-aside designation and represents a competitive award. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.74 to AmerisourceBergen Drug Corp for 60-count bottles of Rifampin 300 mg capsules, with delivery to the company's headquarters in Conshohocken, Pennsylvania. The contract was awarded on August 6, 2025, under firm fixed price terms with an ultimate completion date of August 7, 2025, and utilized no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a contract ceiling value of $1,200.66. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made...
- The Defense Logistics Agency awarded a $1,264.00 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a first-line antibiotic commonly used in the treatment of tuberculosis and other...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) valued at $2,401.32, with an ultimate completion date of August 27, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily for treating tuberculosis and certain other...
- AmerisourceBergen Drug Corp was awarded a delivery order for Rifampin 300 mg capsules (60-count) valued at $2,852.92 by the Defense Logistics Agency on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed pricing and was competitively awarded without set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJK02Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,816.89 on August 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis and other mycobacterial infections, making it an essential pharmaceutical commodity for military and federal healthcare systems. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a prime vendor for federal medical procurement across multiple therapeutic domains. The company's comprehensive contract vehicle with DLA enables it to supply pharmaceuticals, vaccines, and medical supplies to support military healthcare systems globally, including services to the Defense Health Agency and U.S. Coast Guard. The non-set-aside award demonstrates AmerisourceBergen's competitive capability in meeting federal pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/13/25 |